Stock Price Forecast

June 9, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Athenex Inc chart...

About the Company

We do not have any company description for Athenex Inc at the moment.

Please visit https://www.athenex.com/ for more information about the company.

CEO

Johnson Lau

Exchange

NASDAQ

Website

https://www.athenex.com/

$25M

Total Revenue

275

Employees

$1M

Market Capitalization

-0.30

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ATNX News

Athenex Voluntarily Filed For Chapter 11 Proceedings, Shares Plunge

11mon ago, source: Hosted on MSN

On Sunday, Athenex Inc (NASDAQ: ATNX) and certain of its subsidiaries voluntarily filed for Chapter 11 proceedings. Athenex agreed with its lenders to move forward with an expedited sale process ...

Why Athenex (ATNX) Stock Is Getting Obliterated Monday

11mon ago, source: Hosted on MSN

Athenex Inc (NASDAQ: ATNX) shares are trading lower after the company announced it voluntarily filed Chapter 11 proceedings. What Else? Athenex says this expedited sale will enable the company to ...

ImmunityBio Inc. Drug Approved By FDA

20h ago, source: The Post-Journal

A monumental achievement for ImmunityBio, Inc. occurred earlier this week, leaving the door open for potential major benefits ...

Drug approval raises hopes for ImmunityBio, site

2d ago, source: Observer

A monumental achievement for ImmunityBio, Inc., occurred earlier this week, leaving the door open for potential major ...

Athenex Jumps on Plan to Buy Cancer-Therapy Developer Kuur

2y ago, source: TheStreet.com

Shares of Athenex jumped after the biopharma focused on cancer therapies agreed to buy Kuur, a developer of immunotherapies to treat cancer. Shares of Athenex jumped after the biopharma focused on ...

Anthenex Drops as FDA Urges New Trial for Breast-Cancer Drug

3y ago, source: TheStreet.com

Athenex drops as the FDA urged the company to conduct a new clinical trial for its treatment for metastatic breast cancer. Shares of Athenex (ATNX) dropped Monday after the drugmaker said that ...

Pioneer Bancorp Stock (NASDAQ:PBFS), Quotes and News Summary

2mon ago, source: Benzinga.com

Gainers Athenex, Inc. (NASDAQ: ATNX) shares rose 46.6% to $5.44 in pre-market trading after the company announced it acquired Kuur Therapeutics.

Welcome to Inc.'s Directory of B2B Excellence

2mon ago, source: Inc

They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.

About Inc.com | Everything You Need to Know to Grow and Start Your Business

12y ago, source: Inc

Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...

Snap Inc.

2mon ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

‘Food, Inc. 2’ Review: A Second Course

15d ago, source: The New York Times

Share full article “Food, Inc. 2,” directed by Robert Kenner and Melissa Robledo, begins by describing how the last few years have shown the risks of letting a handful of mega-suppliers ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...